Home › Plexiform Neurofibroma
Pag-aaral pangklinika para sa Plexiform Neurofibroma na nagre-recruit sa U.S.
8 pag-aaral para sa Plexiform Neurofibroma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Washington, DC7 pag-aaral
- Philadelphia, PA4 pag-aaral
- Birmingham, AL4 pag-aaral
- Cincinnati, OH3 pag-aaral
- Dallas, TX3 pag-aaral
Ayos sa estado
- Alabama4 pag-aaral
- District of Columbia4 pag-aaral
- Maryland6 pag-aaral
- Ohio3 pag-aaral
- Pennsylvania4 pag-aaral
- Texas3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 5 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02544022Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
Nagre-recruitObservasyonal na pag-aaral
Edad 3 hanggang 120 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06222203Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
Nagre-recruitPhase 1
Edad 3 hanggang 35 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT02390752Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
Nagre-recruitPhase 1
Edad 16 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06502171A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06541847A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
Nagre-recruit
Edad 1 hanggang 120 · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT06507748Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
Nagre-recruitPhase 2
Edad 1 hanggang 8 · Lahat ng kasarian · Na-update May 29, 2026 · NCT06188741PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 4, 2025 · NCT06961565Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.